Literature DB >> 8088734

Defining subgroups of dual diagnosis patients for service planning.

A F Lehman1, C P Myers, L B Dixon, J L Johnson.   

Abstract

OBJECTIVE: The high proportion of persons presenting for treatment of psychiatric disorders who also have comorbid substance use problems severely challenges the capacity of mental health care programs to plan for patients' needs. One of the problems encountered in anticipating the treatment needs of these patients is the wide heterogeneity of their comorbidity, that is, the broadly varying types, severity, and time courses of psychiatric and substance disorders. This paper describes and evaluates a relatively simple conceptual framework for delineating the heterogeneity of patients who are dually diagnosed.
METHODS: A typology of subgroups of patients was defined a priori based on whether patients are singly or dually diagnosed and whether their disorders are current or past. Patients admitted to three treatment facilities in an inner-city catchment area were assigned to one of the subgroups based on administration of the Structured Clinical Interview for DSM-III-R-Patient Version (SCID-P). The subgroups were compared on clinical diagnoses and service needs as measured by the SCID-P and the Addiction Severity Index.
RESULTS: A total of 461 patients were assigned to four mutually exclusive dual diagnosis subgroups--patients with current definite dual diagnoses, current possible dual diagnoses, current substance-induced organic mental disorder, and past definite dual diagnoses--and the two comparison groups. The subgroups differed significantly from each other and from two single-diagnosis comparison groups on axis I diagnoses, types of substance use disorders, and current problem areas.
CONCLUSIONS: The framework developed has potential utility for distinguishing subgroups of dually diagnosed patients relevant for service planning.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8088734     DOI: 10.1176/ps.45.6.556

Source DB:  PubMed          Journal:  Hosp Community Psychiatry        ISSN: 0022-1597


  11 in total

1.  Use of potentially abusive psychotropic substances in psychiatric inpatients.

Authors:  J Modestin; C Nussbaumer; K Angst; P Scheidegger; D Hell
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

2.  An examination of psychiatric comorbidities as a function of gender and substance type within an inpatient substance use treatment program.

Authors:  Kevin W Chen; Annie N Banducci; Leila Guller; Richard J Macatee; Anna Lavelle; Stacey B Daughters; C W Lejuez
Journal:  Drug Alcohol Depend       Date:  2011-04-22       Impact factor: 4.492

3.  Associations with substance abuse treatment completion among drug court participants.

Authors:  Randall Brown
Journal:  Subst Use Misuse       Date:  2010-10       Impact factor: 2.164

4.  Reported comorbidity of mental disorders with substance abuse among psychiatric inpatients in Israel.

Authors:  J Rabinowitz; M Mark; M Popper; M Slyuzberg
Journal:  J Ment Health Adm       Date:  1996

5.  (AAT)n repeat in the cannabinoid receptor gene, CNR1: association with schizophrenia in a Spanish population.

Authors:  Isabel Martínez-Gras; Janet Hoenicka; Guillermo Ponce; Roberto Rodríguez-Jiménez; Miguel Angel Jiménez-Arriero; Elena Pérez-Hernandez; Israel Ampuero; Jose Antonio Ramos-Atance; Tomas Palomo; Gabriel Rubio
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-06-20       Impact factor: 5.270

6.  Exploring the diversity of dual diagnosis: utility of cluster analysis for program planning.

Authors:  D A Luke; C T Mowbray; K Klump; S E Herman; B BootsMiller
Journal:  J Ment Health Adm       Date:  1996

7.  Private sector coverage of people with dual diagnoses.

Authors:  D W Garnick; A M Hendricks; M Drainoni; C M Horgan; C Comstock
Journal:  J Ment Health Adm       Date:  1996

8.  DOUBLE TROUBLE IN RECOVERY: SELF-HELP FOR PEOPLE WITH DUAL DIAGNOSES.

Authors:  Howard S Vogel; Edward Knight; Alexandre B Laudet; Stephen Magura
Journal:  Psychiatr Rehabil J       Date:  1998-03

Review 9.  The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements.

Authors:  Lisa B Dixon; Faith Dickerson; Alan S Bellack; Melanie Bennett; Dwight Dickinson; Richard W Goldberg; Anthony Lehman; Wendy N Tenhula; Christine Calmes; Rebecca M Pasillas; Jason Peer; Julie Kreyenbuhl
Journal:  Schizophr Bull       Date:  2009-12-02       Impact factor: 9.306

10.  HIV risk behavior among psychiatric outpatients: association with psychiatric disorder, substance use disorder, and gender.

Authors:  Michael P Carey; Kate B Carey; Stephen A Maisto; Kerstin E E Schroder; Peter A Vanable; Christopher M Gordon
Journal:  J Nerv Ment Dis       Date:  2004-04       Impact factor: 2.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.